Balanced news tone
News Sentiment
IRIX sentiment intelligence
IRIDEX Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
76/100 classification confidence.
directly relevant articles
high-authority source matches
-2.7% over one week, -1.8% over four weeks, trend inactive, and below fair value.
Form 4 IRIDEX Corporation For: 14 July By Investing.com
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Form 4 IRIDEX Corporation For: 14 July By Investing.com
This article announces the filing of a Form 4 for IRIDEX Corporation on July 14. Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) by company insiders to report changes in ownership of the company's restricted stock. The publication pr
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 21:17
- Source
- Investing.com Canada
IRIDEX CORP (IRIX) grants CFO 30K RSUs and 170K options
IRIDEX CORP (IRIX) awarded its CFO, Romeo R. Dizon, 30,000 restricted stock units (RSUs) and a stock option for 170,000 shares. The RSUs vest in three equal annual installments starting July 10, 2027, and the stock option, with an exercise price of $1.10 per share, expires on Jul
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 20:17
- Source
- Stock Titan
Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q1 Earnings: Integer Holdings (NYSE:ITGR)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 18:07
- Source
- Market source
Form 13D/A IRIDEX CORP For: 13 July By Investing.com
This article reports on the filing of Form 13D/A for IRIDEX CORP on July 13th, as sourced by Investing.com. It is a brief announcement without further details within the body of the text, indicating the release of a regulatory filing for the specified company.
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 14 Jul 2026 00:12
- Source
- Investing.com Nigeria
Novel Inspiration International Co Ltd Intends to Engage with IRIDEX Corporation
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 21:50
- Source
- marketscreener.com
Iridex Corp (Nasdaq: IRIX) investor group reports 29.92% ownership stake
An investor group comprising Novel Inspiration International Co., Ltd., Xinpo Venture Capital Co., Ltd., and Shih-Yao David Lin has reported a 29.92% beneficial ownership stake in Iridex Corp. As of July 10, 2026, Mr. Lin beneficially owns 6,738,238 shares, including common stock
- Tone
- Positive 63/100
- Event
- Deals and strategy
- Published
- 13 Jul 2026 22:11
- Source
- Stock Titan
Form 4 IRIDEX Corporation For: 8 July By Investing.com
This article announces the filing of a Form 4 for IRIDEX Corporation on July 8th, as reported by Investing.com. A Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) by company insiders to report changes in their ownership of the company
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 17:10
- Source
- Investing.com Nigeria
Novel Inspiration gains IRIDEX (IRIX) shares as quarterly note interest
Novel Inspiration International Co., Ltd., a major shareholder in IRIDEX (IRIX), received 111,997 shares of common stock as a quarterly interest payment on a Convertible Promissory Note. Following this non-cash transaction, Novel Inspiration directly holds 551,429 shares, which a
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 12:39
- Source
- Stock Titan
IRIDEX Corp updates retinal laser portfolio as ophthalmology demand evolves
IRIDEX Corp (ISIN US4627191006) is continuously refining its retinal laser systems and glaucoma treatment technologies to meet the evolving demands of ophthalmology practices. The company focuses on a niche market of eye-care specialists, providing equipment for minimally invasiv
- Tone
- Positive 64/100
- Event
- Macro sensitivity
- Published
- 07 Jul 2026 18:11
- Source
- AD HOC NEWS
IRIDEX Corporation (IRIX) Slides Amid Light Trading, Key Support Levels in Focus - Arms Index
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 00:46
- Source
- dars.gov.et
IRIDEX Corp (IRIX) Valuation: PE, PB & Fair Value Analysis
The article provides a valuation analysis of IRIDEX Corp (IRIX), noting its current valuation score of 9.10 and ranking 40th in the Healthcare Equipment & Supplies industry. It highlights the company's P/E ratio of -5.90, which is significantly below its recent high and slightly
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jun 2026 03:14
- Source
- TradingKey
IRIDEX (IRIX) adjourns 2026 shareholder meeting, sets July 10 reconvene date
IRIDEX Corporation has adjourned its 2026 annual meeting of stockholders, originally held on June 12, 2026, without conducting any business. The meeting is now scheduled to reconvene on July 10, 2026, at 8:00 a.m. Pacific Time at the company's Mountain View headquarters. The reco
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 20:14
- Source
- Stock Titan
IRIDEX Corp (IRIX) Institutional Confidence
The article analyzes the institutional confidence in IRIDEX Corp (IRIX), noting its current score of 3.00, which ranks 132nd in the Healthcare Equipment & Supplies industry. Institutional shareholding proportion increased by 16.49% quarter-over-quarter, with James Simons identifi
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 09:14
- Source
- TradingKey
IRIDEX Corp (IRIX) Technical Analysis: Support, Resistance, Indicators & Moving Averages
IRIDEX Corp (IRIX) currently has a price momentum score of 6.78, placing it in the 101st position out of 204 in the Healthcare Equipment & Supplies industry. The stock is trading between a resistance level of $1.25 and a support level of $1.03, suggesting a range-bound swing trad
- Tone
- Positive 62/100
- Event
- Market update
- Published
- 18 Jun 2026 03:41
- Source
- TradingKey
IRIDEX Corp (IRIX) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for IRIDEX Corp (IRIX), highlighting its current earnings forecast score, analyst ratings, and peer comparison within the Healthcare Equipment & Supplies industry. It also includes anticipated revenue and EPS for upcoming quarters, notin
- Tone
- Positive 75/100
- Event
- Earnings
- Published
- 17 Jun 2026 19:41
- Source
- TradingKey
IRIDEX Corp (IRIX) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides an overview of IRIDEX Corp (IRIX) focusing on its dividend and stock split history. It states that the company has distributed a total of $0.00 in dividends over the past five years and reports no data regarding stock splits. The piece is from TradingKey and
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 17 Jun 2026 17:41
- Source
- TradingKey
IRIDEX Corp (IRIX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides a detailed breakdown of IRIDEX Corp's (IRIX) revenue by business segment and geographical region. As of the latest update on Monday, April 6th, the company's revenue is primarily driven by its Retina and G6 segments, with significant contributions from the U
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 17 Jun 2026 17:41
- Source
- TradingKey
IRIDEX (IRIX) CEO surrenders 3,990 shares to cover tax obligations
IRIDEX CORP President and CEO Patrick Mercer reported a tax-withholding disposition of 3,990 shares of Common Stock at $1.12 per share to satisfy tax obligations, rather than through an open-market sale. Following this transaction, Mercer directly holds 368,784 shares. This type
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 23:39
- Source
- Stock Titan
IRIDEX (IRIX) CFO has 2,691 shares withheld to pay taxes
IRIDEX Corp's CFO, Romeo R. Dizon, reported a tax-related share withholding where 2,691 shares of common stock were disposed of at $1.12 per share to satisfy a tax obligation. This was a tax-withholding disposition, not an open-market sale, and after the transaction, Dizon direct
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 23:39
- Source
- Stock Titan
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jun 2026 07:00
- Source
- Market source
Iridex CFO Romeo Dizon buys $1,110 in company stock By Investing.com
Iridex CFO Romeo Dizon recently acquired 975 shares of IRIDEX CORP (NASDAQ:IRIX) common stock for a total of $1,110, at a price of $1.1386 per share. This transaction increases his direct holdings to 135,975 shares. The purchase comes as IRIDEX stock shows a 19% return over the p
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 15 Jun 2026 20:09
- Source
- Investing.com UK
Iridex CFO Romeo Dizon buys $1,110 in company stock
Iridex CFO Romeo R. Dizon recently purchased 975 shares of the company's common stock for $1,110. This transaction increases his direct holdings to 135,975 shares. The purchase occurred as the stock trades near $1.14, having delivered a 19% return over the past year, and analysts
- Tone
- Positive 64/100
- Event
- Market update
- Published
- 15 Jun 2026 19:09
- Source
- Investing.com
IRIDEX (IRIX) CFO Romeo Dizon adds 975 common shares in open-market buy
IRIDEX Corp's Chief Financial Officer, Romeo R. Dizon, purchased 975 common shares in an open-market transaction at an average price of $1.1386 per share. This transaction increases his direct holdings to 135,975 common shares. The filing, a Form 4, indicates a neutral impact and
- Tone
- Positive 67/100
- Event
- Market update
- Published
- 15 Jun 2026 15:40
- Source
- Stock Titan
Insider Buying: Romeo Dizon Acquires Additional Shares of IRIDEX Corp (IRIX)
Romeo Dizon, CFO of IRIDEX Corp (IRIX), recently purchased 1,675 shares, increasing his total holdings to 135,000 shares. This transaction is part of a larger trend of insider buying at IRIDEX, with 50 insider buys and no sells over the past year. Despite the buying activity, the
- Tone
- Positive 65/100
- Event
- Market update
- Published
- 12 Jun 2026 20:40
- Source
- GuruFocus
Iridex CFO Romeo Dizon buys $1,909 in company stock
Iridex CFO Romeo R. Dizon recently acquired 1,675 shares of the company's common stock for $1,909, increasing his direct ownership to 135,000 shares. The stock has gained 21.63% over six months and is considered undervalued by InvestingPro, despite a recent Q1 2026 revenue miss b
- Tone
- Positive 59/100
- Event
- Earnings
- Published
- 12 Jun 2026 19:40
- Source
- Investing.com
IRIDEX (IRIX) CFO Romeo Dizon adds 1,675 shares in open-market stock purchase
IRIDEX Corp. CFO Romeo R. Dizon reported an open-market purchase of 1,675 shares of company common stock at $1.14 per share on June 11, 2026. Following this transaction, Dizon directly owns 135,000 common shares. The acquisition signifies a modest increase to his existing positio
- Tone
- Positive 71/100
- Event
- Deals and strategy
- Published
- 12 Jun 2026 18:40
- Source
- Stock Titan
Iridex CFO Romeo Dizon buys $2,688 in company stock
Iridex CFO Romeo R. Dizon purchased 2,400 shares of the company's common stock for $2,688 on June 8, 2026, increasing his direct holdings to 133,325 shares. This transaction occurred as the stock trades near $1.11, with analysts projecting a potential 148% upside to a target of $
- Tone
- Positive 63/100
- Event
- Analyst action
- Published
- 10 Jun 2026 05:39
- Source
- Investing.com
Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference
Iridex Corporation (Nasdaq: IRIX) announced its participation in the Planet MicroCap Las Vegas 2026 Conference. Management is scheduled to present on Wednesday, June 17, at 4:00 pm PT, with a live and archived webcast available on the company’s website. Iridex is a global leader
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 09 Jun 2026 19:40
- Source
- GlobeNewswire
Iridex CFO Romeo Dizon buys $2,688 in company stock By Investing.com
Iridex CFO Romeo R. Dizon recently purchased 2,400 shares of the company's common stock for $2,688, bringing his total direct holdings to 133,325 shares. This transaction occurred as IRIX shares trade near $1.11, with analysts suggesting a significant potential upside. Despite a
- Tone
- Positive 59/100
- Event
- Market update
- Published
- 09 Jun 2026 18:09
- Source
- Investing.com Nigeria
Watch Iridex’s June 17 Planet MicroCap talk live from Las Vegas
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 07:00
- Source
- Stock Titan